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Francisella tularensis is a highly virulent Gram-negative intracellular pathogen capable of infecting a vast diversity of hosts,
ranging from amoebae to humans. A hallmark of F. tularensis virulence is its ability to quickly grow to high densities within a
diverse set of host cells, including, but not limited to, macrophages and epithelial cells. We developed a luminescence reporter
system to facilitate a large-scale transposon mutagenesis screen to identify genes required for growth in macrophage and epithe-
lial cell lines. We screened 7,454 individual mutants, 269 of which exhibited reduced intracellular growth. Transposon insertions
in the 269 growth-defective strains mapped to 68 different genes. FTT_0924, a gene of unknown function but highly conserved
among Francisella species, was identified in this screen to be defective for intracellular growth within both macrophage and epi-
thelial cell lines. FTT_0924 was required for full Schu S4 virulence in a murine pulmonary infection model. The FTT_0924 mu-
tant bacterial membrane is permeable when replicating in hypotonic solution and within macrophages, resulting in strongly
reduced viability. The permeability and reduced viability were rescued when the mutant was grown in a hypertonic solution,
indicating that FTT_0924 is required for resisting osmotic stress. The FTT_0924 mutant was also significantly more sensitive
to -lactam antibiotics than Schu S4. Taken together, the data strongly suggest that FTT_0924 is required for maintaining pepti-
doglycan integrity and virulence.
Francisella tularensis is a Gram-negative facultative intracellularpathogen capable of infecting over 250 hosts, ranging from
amoebae to humans (1). F. tularensis subspecies tularensis is
highly virulent in mammals, and as few as 25 organisms can cause
a potentially fatal infection in humans (2). The bacterium infects a
variety of cell types, including, but not limited to, macrophages,
dendritic cells, neutrophils, epithelial cells, fibroblasts, and hepa-
tocytes (3–7). F. tularensis replicates to high levels within these cell
types, but the specific mechanisms F. tularensis uses to invade and
replicate within host cells remain poorly understood.
It is essential for F. tularensis to replicate within host cells to
successfully establish an infection and cause disease. Intracellular
replication requires phagosomal escape, followed by adaptation to
and replication in the host cytosol. Upon internalization by a host
cell, the bacterium degrades the phagosome within 30 min and
enters the cytosol (8). Escape from the phagosome is an essential
step in the Francisella life cycle, and mutations in the Francisella
pathogenicity island, which encodes an alternative secretion sys-
tem, fail to escape the phagosome (9–11). Other factors have been
identified that are required for efficient F. tularensis vacuolar es-
cape; however, the specific mechanisms necessary for vacuolar
escape have yet to be determined (12–14). Once in the cytosol,
bacteria replicate to high levels before the host cell undergoes
apoptotic cell death (15–18). Mutants that escape the phagosome
but fail to replicate within the cytosol have been identified, includ-
ing mutants with disruptions in purine biosynthesis genes, dipA or
ripA (12, 19, 20). Francisella mutants defective for phagosomal
escape or cytosolic replication exhibit reduced virulence in mu-
rine infection models, indicating that both processes are essential
for F. tularensis virulence.
A large portion of the Francisella genome encodes proteins of
unknown function. Several genes of unknown function, including
dipA, ripA, and FTT_1676, as well as others, are conserved across
Francisella species and are required for intracellular growth and
virulence (12, 20, 21). To better understand Francisella pathogen-
esis, it is important to identify and elucidate the mechanisms by
which these genes affect bacterial intracellular growth and viru-
lence. Here, we perform a large-scale transposon mutagenesis
screen to identify novel virulence factors required for intracellular
growth. Because F. tularensis infects a diverse set of host cell types
and likely requires different mechanisms for entry and replication
within distinct cell types, we screened our library of mutants
within both macrophage-like (J774) and alveolar-epithelial
(TC-1) cell lines. To validate the efficacy of the screen, we identi-
fied FTL_1286, a previously unidentified gene, and investigated
whether it is required for virulence. FTL_1286 is a gene of un-
known function that is conserved among Francisella species. To
identify mechanisms required for F. tularensis pathogenesis, we
wanted to further elucidate the function of FTL_1286 and its ho-
molog in the highly virulent Schu S4 strain, FTT_0924, in intra-
cellular growth and virulence.
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MATERIALS AND METHODS
Bacterial strains. F. tularensis subspecies holarctica LVS was obtained
from the Centers for Disease Control and Prevention in Atlanta, GA, and
F. tularensis subspecies tularensis Schu S4 was obtained from BEI Re-
sources. Each F. tularensis strain was cultured using chocolate agar plates
supplemented with 1% IsoVitaleX (chocolate agar), brain heart infusion
broth supplemented with 1% IsoVitaleX (BHI), or Chamberlain’s defined
medium (CDM) (22). Escherichia coli DH10B was used for cloning and
cultured using Luria-Bertani (LB) broth or LB agar. For selection, kana-
mycin was used at 50 g/ml for E. coli strains and 10 g/ml for F. tular-
ensis, or hygromycin was used at 200 g/ml for E. coli and F. tularensis. All
cultures were grown at 37°C.
Cell culture. J774A.1 (ATCC TIB-67) cells are a murine macrophage-
like cell line and were maintained in 75-cm2 tissue culture flasks contain-
ing Dulbecco modified Eagle medium with glucose at 4.5 g/liter supple-
mented with 10% fetal bovine serum, 2 mM L-glutamine, and 1 mM
sodium pyruvate. TC-1 (ATCC CRL-2785) is a murine alveolar epithelial
cell line, and TC-1 cells were maintained in 75-cm2 tissue culture flasks
containing RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, 10 mM HEPES, 1.5 g of sodium bicarbonate/liter, and 0.1
mM nonessential amino acids. All tissue culture lines were maintained at
37°C and 5% CO2.
Plasmid vectors and allelic exchange. The luminescent reporter
plasmid (pJB1) was created by cloning the Photorhabdus luminescens
luxCDABE operon from pXB173 (23) into the low-copy shuttle plasmid
pMP831 (24). In-frame, markerless deletions in F. tularensis LVS and F.
tularensis Schu S4 were constructed using pEDL50, a modified version of
the suicide vector pMP812 containing an origin of transfer (25). Suicide
vectors were mated into F. tularensis LVS or F. tularensis Schu S4 using E.
coli S17-1pir, and primary recombinants were selected with 200 g of
polymyxin B/ml and 10 g of kanamycin/ml. Primary recombinants were
grown overnight without selection in BHI and then plated on chocolate
agar containing 10% sucrose. Complementing vectors were constructed
by cloning into pJB3, which was derived from the plasmid pMP831 (24),
respectively, each constitutively expressing luxCDABE. Green fluorescent
protein (GFP) and PhoA fusion constructs were constructed by cloning
the fusions into pEDL17 to allow controlled expression by anhydrotetra-
cycline addition (26).
Mapping transposon insertion sites. Colonies of identified trans-
poson insertion mutants were suspended in water and boiled for 10
min to release the genomic DNA. The lysates were centrifuged to re-
move the bacterial debris, and the remaining supernatant was used as
the template DNA for amplification. Regions surrounding the trans-
poson were amplified by using a primer specific to the transposon and
random primers containing a tagged sequence [GGACACGCGTCGA
CTAGTGG(N10)AA]. The amplified products from the PCR were used
as a template in a subsequent reaction by using a primer complemen-
tary to the tag (GGACACGCGTCGACTAGTGG) and a primer specific
to the transposon. The following products were sequenced (Genewiz)
by using a primer to amplify outward from the transposon.
Transposon mutagenesis screen. An EZ::TN KAN-2 transposome
complex (Epicentre) containing an F. tularensis codon-optimized kana-
mycin cassette (Blue Heron) was electroporated into F. tularensis LVS
harboring pJB1. Transposon mutants were selected on chocolate agar
plates containing 10 g of kanamycin/ml and 200 g of hygromycin/ml.
Individual transposon mutants were grown in BHI broth, with 10 g of
kanamycin/ml and 200 g of hygromycin/ml, overnight in 96-well, black-
walled, clear-bottom plates (Corning). The following day, overnight cul-
tures were screened for growth at an optical density at 600 nm (OD600)
and luminescence using an Infinite M200 Series plate reader (Tecan).
Mutants that failed to grow or luminesce were removed from future ex-
periments. Overnight cultures were diluted 1:50 into 200 l of either J774
medium or TC-1 medium. A 50-l portion of the dilution was added to
either 105 J774 cells or 105 TC-1 cells in 96-well, black-walled, clear-bot-
tom, tissue culture-treated plates, which yielded an average multiplicity of
infection (MOI) of 100. At 2 h postinfection for J774 cells and 3 h postin-
fection for TC-1 cells, the bacteria were removed, and 200 l of their
respective tissue culture media containing 25 g of gentamicin/ml was
added to each infected well. Luminescence was read at 4, 6, and 24 h using
the Tecan plate reader in order to determine the intracellular growth.
Gentamicin protection assays. F. tularensis LVS strains cultured for 3
days on chocolate agar containing 1% IsoVitaleX were used to make over-
night cultures in CDM. The following day, the cultures were diluted to 100
Klett units (109 CFU/ml) in phosphate-buffered saline (PBS). This sus-
pension was diluted 1:10 into either J774 medium or TC-1 medium, and
1 ml was added to 106 J774 or TC-1 cells, respectively, resulting in an MOI
of 100. At 2 h postinfection for J774 cells and 3 h postinfection for TC-1
cells, the bacteria were removed, and 1 ml of medium containing 25 g of
gentamicin/ml was added to the infected wells. At 2 h after the gentamicin
treatment, the medium was removed and washed once with PBS, and the
cells were scraped up, vortexed hard for 1 min, and dilution plated to
enumerate the intracellular bacteria.
Mouse infections. Groups of four 6- to 8-week-old C57BL/6 mice
(Jackson Laboratory) were infected with approximately 100 CFU of the F.
tularensis Schu S4, FTT_0924, or FTT_0924 p0924 strain intranasally.
Mice were sacrificed at 2 h, 1 day, 3 days, 4 days, or 7 days postinfection to
determine organ burdens in the lung, liver, and spleen. Organs were ho-
mogenized using a Biojector (Bioject), and homogenates were serially
diluted and plated onto chocolate agar. Individual colonies were counted
after incubation for 4 days at 37°C to quantify organ burdens.
Subcellular fractionations. Portions (50 ml) of cultures grown over-
night in CDM were lysed via mechanical lysis with 0.1-mm-diameter sil-
icon beads in a bead beater, and crude membrane fractions were pelleted
from whole-cell lysates by centrifugation at 100,000  g for 2 h. Each
supernatant was removed for the soluble fraction. The membrane pellet
was resuspended in 150 mM NaCl, 10 mM Tris, 0.5% Sarkosyl (pH 7.5)
and agitated overnight. The solubilized membrane fraction was then pel-
leted at 100,000  g for 1.5 h. The soluble inner membrane fraction was
removed, and the Sarkosyl insoluble fraction was washed and then resus-
pended in 150 mM NaCl–10 mM Tris (pH 6.5). All fractions were stan-
dardized to equal protein by using a bicinchoninic acid (BCA) assay
(Pierce), run on a 4 to 20% polyacrylamide gradient gel (Bio-Rad), and
transferred to a nitrocellulose membrane. The membranes were probed
with antibodies recognizing hemagglutinin (HA) peptide (Sigma), RipA
(27), IglC (BEI Resources), and Tul4 (BEI Resources) for primary probes
and antibodies conjugated to fluorophores as secondary probes (LI-COR
Biosciences). Blots were visualized with an Odyssey infrared imaging sys-
tem (LI-COR Biosciences).
GFP and PhoA fusion localization assay. Overnight cultures were
grown in CDM broth containing 100 ng of anhydrotetracycline/ml. GFP
fluorescence assays were performed by pelleting 1.5 ml of an overnight
culture and resuspending samples in 50 mM Tris-HCl (pH 8.0), 200 mM
NaCl, and 15 mM EDTA. A total of 200 l of resuspended pellet was
transferred to a black-walled 96-well dish (Nunc), and the plate was read
using a Tecan plate reader with an excitation filter of 485 nm and an
emission filter of 512 nm. PhoA activity assays were performed by pellet-
ing and resuspending overnight cultures in 1 M Tris-HCl (pH 8.0), 1 mM
ZnCl2, 0.01% sodium dodecyl sulfate, and 5% chloroform. The resus-
pended cultures were permeabilized for 5 min at 37°C. Then, 100 l of
permeabilized culture was transferred to a 96-well dish, and 20 l of 0.4%
p-nitrophenyl phosphate in 1 M Tris-HCl (pH 8.0) was added, followed
by incubation at 37°C, and the OD420 was measured every 5 min using a
Tecan Infinite 200 series plate reader for 16 h. The time taken to reach an
arbitrary OD420 was recorded. PhoA activity was calculated as (OD420 
1,000)/(min  OD600  ml of culture volume).
Growth curves. Overnight cultures of F. tularensis grown in CDM
were diluted to an OD600 of 0.05 and seeded into 200 l of CDM or BHI
per well in a 96-well plate (Corning). Cultures were incubated in an Infi-
nite 200M Pro series Tecan plate reader (Tecan) at 37°C with orbital
shaking. The OD600 was measured every 15 min for 48 h. A final concen-
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tration of 2.5 M propidium iodide (PI) was used to measure membrane
permeability, and the fluorescence was measured using a 535-nm excita-
tion and a 617-nm emission. For sucrose viability rescues, overnight cul-
tures were diluted to an OD600 of 0.05 in 10 ml of CDM with or without
sucrose. Aliquots were removed at specific time intervals to measure
the OD.
Intracellular growth was measured by infecting 105 J774 or TC-1 cells
with 107 F. tularensis bacteria in a 96-well black-walled, clear-bottom plate
for 2 or 4 h, respectively. Extracellular bacteria were then removed from
the cells, fresh medium containing 25 g of gentamicin/ml was added,
and the plate was placed in the Tecan plate reader with the conditions of
37°C and 5% CO2 maintained. The luminescence was measured every 15
min for 48 h.
Disc diffusions. Disc diffusions were performed on modified Muel-
ler-Hinton agar supplemented with 1% tryptone, 0.5% NaCl, 0.05% L-
cysteine freebase, 1% glucose, and 0.00025% iron pyrophosphate. F. tu-
larensis was resuspended in PBS (to an OD600 of 1), and a lawn of bacteria
was swabbed onto each plate. Paper discs impregnated with specific anti-
biotics or compounds (Becton Dickinson) were placed on the agar. Plates
were incubated at 37°C for 2 days before the diameters of the inhibition
zones were measured.
Fluorescence microscopy. J774 cells were plated onto 8-well chamber
slides (Nunc) at 3  104 cells per well and allowed to replicate overnight.
F. tularensis Schu S4-GFP or FTT_0924-GFP was used to infect the J774
cells at an MOI of 100 for 2 h, the bacteria were removed, and fresh
medium containing 25 g of gentamicin/ml was added to the cells. To
determine bacterial replication at 24 h postinfection, the medium was
removed and washed once with PBS, and 4% paraformaldehyde was
added for 30 min to fix the cells. The slide was then washed in 50 mM
ammonium chloride to remove residual fixative. To stain the eukaryotic
plasma membrane, the slide was incubated in 10 g of wheat germ agglu-
tinin/ml conjugated to AF647 for 10 min and then washed with PBS.
DAPI (4=,6=-diamidino-2-phenylindole)-containing mounting medium
(Vectashield; Vector Labs) was then added to stain the nucleus.
To determine viability of intracellular bacteria, J774 macrophages
were infected with Schu S4-GFP or FTT_0924-GFP strains at an MOI of
100. At 2 h postinfection, the bacteria were removed, and fresh medium
containing 25 g of gentamicin/ml was added to the infected cells. At 16 h
postinfection, the infected J774 macrophages were stained as described
previously (28). Briefly, infected macrophages were permeabilized for 15
min in PBS containing 0.1% saponin and 3% bovine serum albumin
(permeabilization buffer). Next, the infected cells were stained with 2.6
M PI and an anti-F. tularensis lipopolysaccharide (LPS) antibody (as an
internal permeabilization control) for 12 min. The cells were then washed
three times with permeabilization buffer and fixed in 4% paraformalde-
hyde. The fixed cells were mounted with DAPI-containing mounting me-
dium (Vectashield; Vector Labs) to stain the nucleus.
Transmission electron microscopy. Wild-type F. tularensis Schu S4
and FTT_0924 cells were grown overnight in CDM containing 300 mM
sucrose to maintain the structural integrity of the mutant strain. Bacteria
were then reseeded into fresh CDM containing 300 mM sucrose at an
OD600 of 0.1 and allowed to grow for an additional 6 h. Bacteria were then
pelleted and resuspended in fixative buffer (2% glutaraldehyde, 2% para-
formaldehyde, 300 mM sucrose, and 150 mM sodium phosphate, pH 7.4)
for at 4°C overnight. Samples were then fixed in 0.15 M sodium phosphate
and 1% osmium tetroxide. Fixed samples were dehydrated through a
series of treatments with 30, 50, 75, 90, and 100% ethanol and propylene
oxide and embedded in Spurr’s low-viscosity epoxy resin (Polysciences).
Sections (70 to 80 nm) were cut with a diamond knife and mounted on
200 mesh Formvar/carbon-coated copper grids and stained with 4%
aqueous uranyl acetate and Reynolds’ lead citrate. Samples were observed
using a LEO EM910 transmission electron microscope operating at 80 kV
(Carl Zeiss Microscopy, LLC), and digital images were acquired using a
Gatan Orius SC1000 CCD Digital Camera with Digital Micrograph 3.11.0
(Gatan, Inc.).
RESULTS
F. tularensis luminescence reporter functions as a surrogate
measurement for intracellular growth. F. tularensis LVS express-
ing pJB1, a luminescence reporter plasmid constitutively express-
ing Photorhabdus luminescens operon luxCDABE, was used to de-
termine whether luminescence could act as a reporter for
intracellular growth within host cells. J774A.1 macrophages
(J774) were infected with either LVS, LVS harboring pJB1 (LVS
LUX), or ripA mutant, a mutant that does not grow inside mac-
rophages, harboring pJB1 (ripA LUX) (20). Luminescence was
measured at 4 and 24 h postinoculation; after each reading, the
intracellular bacteria were enumerated by dilution plating. From 4
to 24 h postinoculation, both LVS and LVS LUX had increased
intracellular numbers of roughly 100-fold, indicating that pJB1
did not significantly affect intracellular growth (Fig. 1). There was
roughly a 100-fold increase in luminescence between 4 and 24 h
postinoculation in LVS with pJB1, indicating that increased lumi-
nescence was directly proportional to the increase in intracellular
bacterial numbers. There was no increase in luminescence in the
LVS vector-only control between 4 and 24 h, showing that there
were minimal background levels for this reporter system. Also, the
absence of a significant change in luminescence or intracellular
burden between 4 and 24 h for ripA LUX further indicated that
luminescence can be used as an accurate measurement for intra-
cellular growth.
Transposon mutagenesis screening identifies growth-defi-
cient mutants in J774A.1 macrophages or TC-1 epithelial cells
using a luminescence reporter system. LVS LUX was trans-
formed with an EZ::TN KAN-2 transposome complex (Epicen-
tre) containing a kanamycin resistance cassette that was codon
optimized for F. tularensis (Blue Heron). A total of 7,614 individ-
ual mutants were picked and propagated in BHI broth overnight.
Of these, 160 mutants failed to grow or luminesce and were dis-
counted from further experiments, leaving 7,454 mutants to be
tested for intracellular growth. J774 macrophages and TC-1 epi-
thelial cells propagated in a 96-well format were infected with each
individual mutant. The initial luminescence was measured at 4 h
(J774) or 6 h (TC-1) and at 24 h to determine the intracellular
growth. A total of 356 mutants from the primary screening exhib-































FIG 1 Luminescence as an indication for intracellular growth. The intracel-
lular replication of LVS, LVS LUX, and LVS ripA LUX in J774 macrophage
cells was measured via luminescence (right axis) and dilution plating (left axis)
for CFU at 4 and 24 h postinfection. RLU, relative light units. Each sample was
read for luminescence; the infected macrophages were then lysed, and the
intracellular bacteria were enumerated by dilution plating. The bars represent
three independent experiments performed in triplicate.
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These 356 mutants were reevaluated in triplicate for intracellular
growth in both J774 and TC-1 cells using the same luminescence
reporter system. Of these, 269 mutants from the primary screen
repeated a growth defect. The transposon insertion sites for all 269
mutants were identified by amplifying the region surrounding the
transposon insertion by semidegenerate PCR, followed by DNA
sequence analysis (Genewiz), and comparison to the LVS whole-
genome sequence (see Table S2 in the supplemental material). The
269 transposon insertions mapped to 74 genes and 3 pseudogenes.
To further eliminate false positives, representative mutants with
genes with only one transposon insertion were tested in standard
gentamicin protection assays, identifying 68 genes and 2 pseudo-
genes as being required for intracellular growth (Table 1 and Fig.
2). To the best of our knowledge, 14 of the 68 genes were not
previously identified as required for virulence or intracellular
growth in any strain of Francisella.
The FTL_1286 and FTT_0924 loci are required for intracel-
lular growth. One transposon mutation mapped to FTL_1286, a
gene of unknown function that has not been identified as a viru-
lence factor for any Francisella species. The mutant with the trans-
poson mutation exhibited no growth within J774 macrophage
cells but had observable growth within the TC-1 epithelial cells
(see Table S2 in the supplemental material). To determine
whether the FTL_1286 locus was required for intracellular growth,
a markerless, in-frame deletion was constructed of the FTL_1286
locus and growth in macrophages was determined. In J774 cells,
the mutant with the transposon mutation disrupting the
FTL_1286 locus and FTL_1286 expressing pJB3 (shuttle vector
expressing P. luminescens luxCDABE) had no observable intra-
cellular growth, as determined by the luminescence reporter
system (Fig. 3A). However, growth of the FTL_1286 p1286
complemented strain grew to similar levels as wild-type LVS in
macrophages, indicating that FTL_1286 is required for the intra-
cellular replication of LVS (Fig. 3A). Since there is 100% amino
acid sequence identity between FTL_1286 and the FTT_0924 ho-
molog in the highly virulent Schu S4 strain, we hypothesized that
FTT_0924 was also required for intracellular growth of Schu S4.
Deletion of the homologous FTT_0924 locus in the Schu S4 strain
resulted in reduced intracellular growth in J774 cells that was
complemented by expressing FTT_0924 in trans (Fig. 3B) in the
mutant strain. Interestingly, the LVS mutant with the transposon
mutation in FTL_1286 exhibited some growth within the TC-1
epithelial cells; however, the FTL_1286 strain of LVS and the
FTT_0924 strain of Schu S4 exhibited no observable growth
within epithelial cells, indicating that the transposon mutation did
not fully abolish the function of FTL_1286 or that the transposon
mutant acquired a mutation partially compensating for the ge-
netic disruption (Fig. 3D and see Table S2 in the supplemental
material).
To verify that FTT_0924 was required for intracellular growth
and did not simply affect the bacterial luminescence reporter, we
performed gentamicin protection assays in J774 and TC-1 cells,
and the intracellular burdens were quantified by dilution plating
(Fig. 3C and D). In both J774 and TC-1 cells, the FTT_0924
strain did not exhibit intracellular growth, and intracellular
growth could be complemented to near wild-type levels by ex-
pressing FTT_0924 in trans. Fluorescence microscopy analysis of
GFP-expressing strains was also performed to visualize intracellu-
lar growth of the FTT_0924 mutant (Fig. 3E and F).
FTT_0924 is required for virulence in mice. Since FTT_0924
is required for F. tularensis Schu S4 intracellular growth, we
wanted to determine whether FTT_0924 was required for Schu S4
virulence in a mouse pulmonary infection model. C57BL/6 mice
were inoculated intranasally with 100 CFU of the wild-type Schu
S4, FTT_0924, or FTT_0924 p0924 strain. At 2 h and at 1, 3, 4,
and 7 days postinoculation, the bacterial burdens were enumer-
ated from the lungs, livers, and spleens of the infected mice. At 2 h
postinfection, the lungs of mice were harvested and dilution
plated. Equal numbers of bacteria were recovered from the lungs
of mice infected with each bacterial strain, indicating that the mu-
tant and wild-type organisms accessed the lung at equivalent effi-
ciencies (data not shown). At day 1, mice infected with the
FTT_0924 mutant had significantly reduced burdens in the
lungs compared to the wild-type and complemented strains. No
bacteria were detected in livers or spleens of animals infected with
any strain at day 1. By day 3, mice infected with the FTT_0924
mutant had significantly reduced burdens in the lungs and spleens
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FIG 2 Screening procedure used to identify genes required for intracellular
growth. Each mutant identified in the primary screen with reduced growth in
J774 or TC-1 cells was rescreened in triplicate in J774 and TC-1 cells. Trans-
poson insertions were mapped in rescreened mutants with growth defects in
either or both cell lines. If only one transposon insertion mapped to a specific
gene, the mutant was rescreened in a standard gentamicin protection assay.
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compared to the wild-type and complemented strains. The
FTT_0924 strain did not robustly infect the livers of the animals,
whereas there were significant bacterial burdens observed in both
the wild-type and complemented strains (Fig. 4). Interestingly,
there was no change in bacterial burden between day 3, day 4, and
day 7 in mice infected with the FTT_0924 mutant in any organ
tested, indicating that the FTT_0924 mutant had reached a bur-
den where bacterial growth and killing occurred at equal rates,
whereas significant growth was observed in mice infected with the
wild-type and complemented strains (Fig. 4). No data were taken
for animals infected with wild-type Schu S4 or the complemented
strain at day 7 because animals infected with these strains became
moribund at day 4, which required the animals to be euthanized.
Overall, these data indicate that FTT_0924 was required for full
virulence of F. tularensis Schu S4 in a pulmonary murine infection
model.
FTT_0924 is required for resisting osmotic stress during
growth in liquid culture. To characterize the FTT_0924 mutant,
we monitored the general growth characteristics of the
FTT_0924 strain in liquid culture. The Schu S4 and FTT_0924
strains were grown in CDM for 36 h, and the OD600 was measured
every 6 h. After 36 h of growth, Schu S4 reached an OD600 of 2.75,
while the FTT_0924 mutant reached an OD600 of 1.05, indicat-
ing a defect for growth in liquid culture (Fig. 5A). To determine
whether there was any difference in the number of viable bacteria
at each point, wild-type Schu S4 and FTT_0924 strains were
enumerated by dilution plating. Strikingly, there were 100- to
1,000-fold fewer viable bacteria per OD600 in cultures with the
FTT_0924 mutant (Fig. 5B). We next sought to determine
whether the viability defect of the FTT_0924 mutant strain oc-
curred in other conditions, including growth on solid agar or in
PBS suspension. This viability defect was not observed after bac-
terial growth on chocolate agar plates, determined by resuspend-
ing plate-grown bacteria in PBS to an OD600 of 1 and dilution
plating, indicating that the mutant strain specifically did not tol-
erate growth in liquid culture (Fig. 5C). Further, this viability
defect in liquid culture was only observed with actively replicating



















































































FIG 3 Impact of FTL_1286 and FTT_0924 on intracellular growth. (A and B) Intracellular growth of LVS LUX, Tn:FTL_1286, FTL_1286 LUX, and FTL_1286
p1286 strains (A) and Schu S4, FTT_0924 LUX, and FTT_0924 p0924 strains (B), as indicated via luminescence every 30 min. (C and D) J774 (C) or TC-1 (D)
cells infected with Schu S4, FTT_0924, or FTT_0924 p0924 strains measured at 4 and 24 h by dilution plating. (E and F) Representative images (n  30) of J774
cells at 24 h postinfection with the FTT_0924-GFP (E) or Schu S4-GFP (F) strain. Scale bars, 10 m. Red indicates wheat germ agglutinin staining, blue indicates
DAPI, and green indicates GFP bacteria. Three independent experiments were performed for each panel.
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not reduce the numbers of viable CFU recovered for either the
Schu S4 or the FTT_0924 strain (Fig. 5D).
One reason for the reduced viability in liquid culture might be
that the FTT_0924 mutant is sensitive to osmotic stress from a
hypotonic solution. To test this hypothesis, we increased the os-
molarity of the medium to prevent the influx of water into the
bacterial cytoplasm, resulting in bacterial swelling and eventual
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FIG 4 Effect of FTT_0924 on Schu S4 growth and dissemination in a mouse model of infection. C57BL/6 mice were infected intranasally with 100 CFU of the
Schu S4 (WT), FTT_0924, or FTT_0924 p0924 strains. At 2 h and days 1, 3, 4, and 7 postinfection, organs were harvested, homogenized, serially diluted, and
plated on chocolate agar to determine bacterial burdens. A horizontal dashed line indicates the limit of detection of the assay. **, P 	 0.01; ***, P 	 0.0001 (as








































































































































FIG 5 Bacterial viability of FTT_0924 cells during in vitro growth. Schu S4 and FTT_0924 cells were grown in CDM, and the OD600 (A) and the viable bacteria per
OD600 (B) were measured. (C) The bacterial viability was measured after 24 h of growth on chocolate agar, resuspension in PBS, and dilution plating. (D) Schu S4 and
FTT_0924 cell viability was measured by inoculating PBS at an OD600 of 1; samples were then allowed to shake for 24 h and dilution plated. The OD600 (E) and the viable
bacteria per OD600 (F) were quantified at 24 h postinoculation from Schu S4 and FTT_0924 cells grown in CDM with various amounts of sucrose. All of the results are
representative of at least three independent experiments. *, P 	 0.05; **, P 	 0.01; n.s., not significant (as determined by using the Student t test).
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Wild-type Schu S4 and FTT_0924 strains were inoculated at an
OD600 of 0.05 in CDM supplemented with either 0, 100, or 300
mM sucrose and then grown for 24 h at 37°C. Both OD600 and the
numbers of viable bacteria were measured after 24 h of growth to
determine whether growth in high-osmolarity medium rescued
the viability defect of the FTT_0924 mutant after growth in liq-
uid culture. In medium containing sucrose, the FTT_0924 mu-
tant reached a terminal OD600 equal to that of the wild type, indi-
cating a rescue of the FTT_0924 mutant growth defect
determined by OD600. Likewise, the number of viable mutant bac-
teria per OD600 was restored to near wild-type levels in the pres-
ence of sucrose (Fig. 5E and F), suggesting that FTT_0924 pep-
tidoglycan integrity was compromised, resulting in membrane
permeability and an increased susceptibility to osmotic stress.
FTT_0924 mutant membrane is permeable under hypo-
tonic conditions. Since FTT_0924 mutant viability was rescued
with the addition of sucrose, we wanted to determine whether the
membranes of the mutant bacteria were permeable specifically
during growth under hypotonic conditions. Wild-type and the
FTT_0924 strains were grown in CDM containing propidium
iodide (PI), which is membrane impermeable and will enter the
bacterial cell and incorporate into the chromosomal DNA only if
the integrity of the bacterial membrane is compromised. Once PI
binds DNA, it becomes fluorescent, and thus an increase in PI
fluorescence indicates that the bacterial membranes are perme-
able. Wild-type and FTT_0924 strains were grown in CDM,
CDM with sucrose, and CDM with gentamicin, a bacteriolytic
antibiotic providing a positive control for PI incorporation. The
OD (Fig. 6A) and PI fluorescence (Fig. 6B) were measured simul-
taneously every 30 min for 24 h. Wild-type bacteria grown in
CDM or CDM with added sucrose did not have any appreciable
increase in PI fluorescence, whereas bacteria grown in CDM plus
gentamicin (inoculated at a higher OD600 of 0.3) exhibited signif-
icant PI fluorescence (Fig. 6B). In contrast, the FTT_0924 strain
showed a significant increase in PI fluorescence within the first 4 h
of growth in CDM, which did not occur in CDM with added
sucrose (Fig. 6B), indicating that the FTT_0924 strain’s bacterial
membrane was permeable only when grown in a hypotonic solu-
tion. Further, this increase in membrane permeability (Fig. 6B) in
CDM correlated with the decrease in viability within 6 h of growth
in CDM (Fig. 5B), indicating that the cellular defect was observ-
able immediately upon initiation of bacterial replication.
Since the membrane of the FTT_0924 mutant was permeable
during replication under hypotonic conditions, we next tested
whether the FTT_0924 cell membrane was also permeable in
macrophages. J774 cells were infected with either wild-type Schu
S4-GFP or the FTT_0924-GFP mutant for 16 h, and the macro-
phages were then permeabilized with saponin and stained with PI.
We found that 5% of the intracellular Schu S4-GFP and 40% of
the FTT_0924-GFP mutant stained positive for PI, indicating
that the FTT_0924 mutant exhibited a significant increase in
membrane permeability in macrophages (Fig. 7). These data sug-
gest that the observed viability defect of the FTT_0924 mutant is
the reason for reduced intracellular growth in host cells and likely
in vivo.
The observed membrane permeability of the FTT_0924 mu-
tant suggests that it may be involved in maintaining the overall
structure of F. tularensis. Bacteria growing in CDM with sucrose
were fixed, and transmission electron microscopy was performed
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FIG 6 Membrane permeability of Schu S4 and FTT_0924 cells in liquid culture. Schu S4 and the FTT_0924 mutant were grown in CDM, CDM plus
300 mM sucrose, or CDM plus 50 g of gentamicin/ml; each medium also contained 2.5 M PI. (A) The OD600 of Schu S4 and FTT_0924 cells was
measured every 30 min over 24 h. (B) The fluorescence from PI incorporation into bacterial DNA of Schu S4 and FTT_0924 cells was measured every
30 min over 24 h. All of the results are representative of at least three independent experiments.
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morphological differences compared to wild-type bacteria. No
obvious observable physiological differences in cell size, shape,
membrane structure, or other defects were visible between the
wild-type and FTT_0924 strains (see Fig. S1 in the supplemental
material). This suggests that membrane permeability in hypotonic
solution is not due to an altered bacterial structure of the
FTT_0924 mutant.
FTT_0924 protein localizes to the inner membrane facing
the periplasm. Determining FTT_0924 localization could provide
insight into how the protein contributes to osmotic stress resis-
tance. Membrane fractions were prepared from the FTT_0924
mutant expressing FTT_0924 protein with a C-terminal HA tag
(FTT_0924-HA). Soluble, inner-membrane and outer-mem-
brane fractions were probed with antibodies recognizing HA,
IglC, RipA, or Tul4 to determine protein localization. FTT_0924
localized to the inner membrane fraction and fractionated with
the same pattern as RipA, a known inner membrane protein (Fig.
8A) (20).
FTT_0924 localized to the inner membrane. Since there is only
one predicted transmembrane domain (TMHMM) at the extreme
N terminus, the majority of the protein must be located within the
cytoplasm or periplasm. To discern between these two possibili-
ties, we adapted a GFP/PhoA fusion system to function in Franci-
sella species (27). Constructs expressing translational fusions of
GFP or PhoA to the C terminus of FTT_0924 were constructed
and expressed in F. tularensis Schu S4. Since GFP fluoresces only
when expressed in the cytoplasm and PhoA is only active in the
periplasm, cytoplasmic or periplasmic localization can be deter-
mined based on fluorescence/activity ratios expressed by the fu-
sion construct strains. The GFP and PhoA activities were mea-
sured for each fusion, and the ratios of the GFP and PhoA
activities were used to determine localization. BioF, involved in
biotin biosynthesis, and BlaB (
-lactamase) were used as cytoplas-
mic and periplasmic controls, respectively. Fusion of the
FTT_0924-GFP-expressing strain exhibited near-background lev-
els of fluorescence and the FTT_0924-PhoA-expressing strain ly-
sate exhibited PhoA activity, indicating periplasmic location of the
expressed fusion proteins (Fig. 8B). Together, these data indicate
that FTT_0924 was localized in the inner membrane and facing
the periplasmic space, where FTT_0924 may be directly involved





























FIG 7 FTT_0924 is required to maintain membrane integrity in host cells. (A to C) Representative Schu S4-GFP cells (green) (A), PI staining (red) (B), and
merged (C) images, including DAPI staining (blue) of J774 macrophages infected with Schu S4-GFP at 16 h postinfection. (D to F) Representative FTT_0924-
GFP cells (green) (D), PI staining (red) (E), and merged (F) images, including DAPI staining (blue) of J774 macrophages infected with the FTT_0924-GFP
mutant at 16 h postinfection. All samples were also stained with anti-Francisella LPS as an internal permeabilization control (data not shown). (G) Percent
colocalization of GFP bacteria and PI staining from intracellular bacteria. The data were analyzed from n  200 infected macrophages from two independent























FIG 8 Localization of FTT_0924. (A) Inner membrane (IM), outer membrane (OM), soluble (Sol), and whole-cell lysate (WCL) samples were prepared via
Sarkosyl extraction from Schu S4 and FTT_0924 p0924-HA cells (FTT_0924-HA). Proteins that reside in the cytosol (IglC), inner membrane (RipA), and outer
membrane (Tul4) served as fraction purity controls. Lanes were loaded with equal amounts of protein, as determined by BCA assay. (B) Schu S4 cells expressing
BioF, BlaB, or FTT_0924 as translational fusions to PhoA or GFP were tested for GFP or PhoA activity, and the results are presented as the ratio of the two
activities. The data represent at least three independent experiments.
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The FTT_0924 mutant is sensitive to -lactam antibiotics.
Because FTT_0924 is localized in the periplasm and is sensitive to
osmotic stress, we hypothesize that FTT_0924 is involved in
regulating peptidoglycan remodeling and therefore that the
FTT_0924 mutant would be sensitive to specific stresses affect-
ing the cell wall and peptidoglycan. We therefore tested the sensi-
tivity of the FTT_0924 mutant to specific antibiotics and other
compounds via disc diffusion assays. Suspensions of wild-type
Schu S4, the FTT_0924 mutant, or the acrB strain, a Francisella
mutant with a defect in the drug efflux system, were swabbed onto
modified Mueller-Hinton agar plates, and paper discs containing
each compound were placed on each plate. The diameters of the
zones of inhibition were measured after 2 days of incubation at
37°C. The acrB mutant displayed increased sensitivity to several
hydrophobic drugs as previously described, whereas the
FTT_0924 mutant displayed a different pattern of antibiotic sen-
sitivities, indicating that the sensitivities of the FTT_0924 mu-
tant do not affect the function of the known drug efflux mecha-
nisms (Table 2) (29). Interestingly, the FTT_0924 strain
displayed significantly increased sensitivity to 
-lactam antibiot-
ics compared to the wild type. It should be noted that the
FTT_0924 mutant was also sensitive to macrolide antibiotics
and rifampin, which may be a result of either damaged pepti-
doglycan or an indication that FTT_0924 may play a role in other
cellular processes. Overall, these data further demonstrate that
FTT_0924 is required to maintain peptidoglycan integrity and dy-
namics.
DISCUSSION
Luminescence is a commonly used reporter in prokaryotic sys-
tems and was recently first used in F. tularensis (23). Here, we used
bacterial luminescence as a reporter for growth within macro-
phages where bacterial burden increased proportionally with lu-
minescence. Using this reporter system, we screened 7,454 trans-
poson mutants for growth in macrophage and epithelial cell lines.
Of these mutants, 269 with transposon insertions had a growth
defect in one or both cell types, which mapped to 74 specific genes.
The list of 74 genes was further narrowed to 68 genes by targeted
phenotypic screening of the transposon mutants. The F. tularensis
LVS genome contains about 1,800 genes, and testing 7,454 trans-
poson insertion mutants should identify an average of four trans-
poson insertion mutations per gene if there was an unbiased dis-
tribution of transposon insertions. The 269 transposon mutations
that impacted intracellular growth mapped to 68 genes, 4-fold
fewer genes. All 8 genes in the purine biosynthesis pathway (that
are predicted as nonredundant and not essential) and 5 of 6 genes
required for biotin biosynthesis were identified in this screen, sug-
gesting that the library of 7,454 mutants contained minimal bias of
insertion locations with a high level of genomic coverage (30).
The majority of mutants identified in the screen had similar
growth defects in both J774 and TC-1 cell lines (disruptions in 50
of 68 genes identified). The majority of genes involved in purine
biosynthesis and transporters did not replicate to any detectable
level in either cell type, reiterating the known dependence on pu-
rine biosynthesis and dependence on host nutrients for intracel-
lular growth and virulence (7, 19, 31, 32). Mutants that grew to
intermediate levels in both cell types included those involved in
essential bacterial processes, carbon metabolism and DNA repli-
cation and repair. It is possible that the defect in intracellular
replication of many of these mutants could be attributed to an
overall fitness defect and are not specifically required within a host
cell. Interestingly, the screen identified two predicted pseudogenes
as required for intracellular growth, both predicted to be dis-
rupted genes encoding transporters. This finding suggests that
these and potentially other predicted pseudogenes may not be
inactive and may encode functional proteins or untranslated ele-
ments required for virulence or other cellular processes.
Mutants with growth defects in macrophages but not TC-1
epithelial cells included those with insertions in genes encoding
proteins involved in LPS and biotin biosynthesis. Mutants with
mutations in the LPS biosynthesis pathway likely did not show
observable luminescence in the J774 cells due to the hypercyto-
toxic phenotype previously observed (33). Interestingly, these
mutants grew to wild-type levels in the TC-1 epithelial cells, indi-
cating that functional LPS is not essential for intracellular growth
in all cell types and that the host recognition receptors or signaling
pathways that results in hypercytotoxicity may be myeloid spe-
cific. Mutants with defects in biotin biosynthesis grew in TC-1 but
not in J774 cells because the tissue culture medium used for TC-1
cells was supplemented with biotin, whereas the medium used for
J774 cells was not. Growth of the biotin biosynthetic mutants in
J774 cells was restored by supplementing the medium with biotin
(data not shown). The limited number of mutants that grew in
macrophages but not in epithelial cells had defects in synthesis or
the uptake of aromatic amino acids. It is possible that the reduced
growth of these mutants in TC-1 cells was due to the lower con-
centrations of phenylalanine, tyrosine, and tryptophan in TC-1
TABLE 2 Sensitivity of Schu S4, FTT_0924 mutant, and acrB mutant strains to specific compounds
Antibiotic or reagent Class
Inhibition zone mean diameter (mm)  SD
Schu S4 FTT_0924 mutant acrB mutant
Nalidixic acid Quinolone 32.7  0.6 31  1 33.7  0.7
Ciprofloxacin Fluoroquinolone 36.7  0.7 37.7  0.7 38.7  0.7
Erythromycin Macrolide 19  0 20.3  1.5 34.3  1.2
Tetracycline Tetracycline/polyketide 21  0 21.3  0.6 26  0
Ethidium bromide Intercalator 15.7  0.6 12.3  0.6 21  0
SDS Detergent 14  0 17  0 29.3  0.6
Ceftriaxone 
-Lactam 6  0 24.3  2.3 6  0
Amoxicillin  clavulanic acid 
-Lactam 6  0 17.3  2.5 6  0
Kanamycin Aminoglycoside 21.3  0.6 26  0 23  0
Gentamicin Aminoglycoside 26  0 31.3  0.6 26.3  0.6
Rifampin Rifamycin 22.3  0.6 35.3  0.6 26  0
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medium than in J774 medium. The growth defects observed in the
purine, biotin, and aromatic amino acid biosynthetic pathways
illustrate that several essential nutrients are limiting in the cytoso-
lic compartment.
We here identified FTT_0924 as a factor required for osmotic
stress resistance, intracellular growth within macrophages and ep-
ithelial cells, and virulence in a pulmonary murine infection
model. FTT_0924 is highly conserved among all Francisella species
and encodes a 132-amino-acid protein of unknown function but
which contains no sequence similarity to proteins outside the
Francisella genus. We found that FTT_0924 is required to main-
tain resistance to osmotic stress in liquid culture during replica-
tion and that deletion of the FTT_0924 locus results in membrane
permeability in a hypotonic solution. In solution, the OD600 of the
FTT_0924 mutant was maintained, but viability was severely
reduced, suggesting that the mutant bacteria are leaky but that full
bacterial lysis does not occur. This viability defect can be rescued
when the osmolarity of the solution is increased, indicating that
the viability defect and membrane permeability only occur in hy-
potonic solution. Interestingly, the total solute concentration of
our defined medium is 456 mM, and the isotonic solute concen-
tration of a J774 cell is roughly 290 mM, so the host cell cytosol is
a hypotonic environment for F. tularensis (34). This observation
correlates with the data demonstrating that the FTT_0924 mu-
tant membrane was permeable to PI in J774 macrophages, sug-
gesting that the intracellular growth and virulence defect of a
FTT_0924 mutant is due to loss of membrane integrity from
osmotic stress experienced within the host cytosol.
In Schu S4 cells, FTT_0924 localizes with the inner membrane
and faces the periplasm, placing it in an optimal location to di-
rectly modulate peptidoglycan dynamics. The FTT_0924 mu-
tant is also hypersensitive to 
-lactam antibiotics, further suggest-
ing the role of FTT_0924 in peptidoglycan stability. Transmission
electron microscopy analysis revealed no gross morphological dif-
ferences in the bacterial shape, size, or membrane structure in the
FTT_0924 strain compared to wild-type Schu S4; thus, the mu-
tant bacteria maintained a structure similar to that of the wild
type. Together, these data demonstrate that FTT_0924 plays a role
in maintaining the integrity of the peptidoglycan but that it is not
required for maintaining gross bacterial structure.
To survive and replicate, bacterial pathogens must adapt to and
resist stresses within different host environments. Identifying the
specific stresses pathogens must overcome within host cells will
help us to define the mechanisms required for intracellular growth
and virulence and identify potential targets for therapeutics. We
performed a large-scale genetic screen to identify genes required
for F. tularensis intracellular growth. We identified several genes
(genes not previously recognized as required for intracellular
growth and virulence) involved in metabolite biosynthesis and
uptake, indicating that the host cell cytoplasm is limiting in several
essential nutrients. We also identified FTT_0924, a gene of un-
known function, and determined that FTT_0924 is involved in
modulating peptidoglycan dynamics. By further investigating the
role of FTT_0924 in peptidoglycan dynamics, we can understand
how F. tularensis modulates its peptidoglycan and elucidate how
optimal peptidoglycan dynamics is required for intracellular
growth and virulence. Identifying new genes required for F. tula-
rensis intracellular growth, such as specific amino acid biosyn-
thetic genes and FTT_0924, and defining the role of these genes in
intracellular replication will help to define the specific mecha-
nisms of how F. tularensis infects and replicates within host cells
and causes disease.
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